The Schwab US Dividend Equity ETF (SCHD) has rallied about 10% since early October, supported by stronger earnings from key holdings like Texas Instruments and UnitedHealth, as well as inflows into dividend-focused funds. SCHD trades at roughly 18.6 times earnings, closing half the valuation gap with its peers, suggesting a fair value near $38.88, about 8% above current levels. Near-term catalysts include Home Depot's earnings and SCHD's December dividend distribution. However, risks such as rising interest rates, falling oil prices, and a shift back into AI stocks could challenge SCHD's performance despite its earnings growth.
As of Nov 16, 2026 00:11 WIB, SCHD trades at USD 36.12 on Pluang, showing a modest 1-day gain of 0.53%. Key holdings like Texas Instruments are down 2.81% at USD 303.60, while UnitedHealth is slightly up 0.58% at USD 407.46. Home Depot remains stable with a 0.12% increase at USD 348.69, reflecting steady investor interest in these dividend-paying stocks. Notably, SCHD's market cap stands at $124.41 billion, highlighting its significant presence in the dividend equity space.
The 4-Factor Dividend Growth Strategy, which selects stocks based on free cash flow to debt, dividend growth, return on capital employed, and forward yield, has achieved an average return of 14.98%, outperforming the Schwab US Dividend Equity ETF (SC...
The Schwab U.S. Dividend Equity ETF (SCHD) is rated a Buy due to expected catalysts in 2027 that support capital appreciation, strong free cash flow, and dividend growth. Its top holdings, including Texas Instruments, Home Depot, Coca-Cola, and Amgen...
